Skip to main content
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1990 Nov;82(2):350–354. doi: 10.1111/j.1365-2249.1990.tb05451.x

Anomalous expression of HLA class II molecules on keratinocytes and fibroblasts in hypertrophic scars consequent to thermal injury.

C Castagnoli 1, M Stella 1, G Magliacani 1, S T Alasia 1, P Richiardi 1
PMCID: PMC1535117  PMID: 1700745

Abstract

Immunoperoxidase staining of skin sections obtained from 11 hypertrophic scars, six normotrophic scars and three samples of normal skin were performed using anti-HLA monoclonal antibodies (HLA-DR, -DQ, class I), anti-interleukin-2 receptor (IL-2R) and anti-CD1. Sections from all hypertrophic scars showed an anomalous expression of HLA-DR molecules on keratinocytes and fibroblasts. Moreover hypertrophic scars were characterized by dense infiltrates of IL-2R-positive cells and by the presence of abundant Langerhans (CD1+) cells in the epidermis and dermis. These results support the hypothesis that immunologic mechanisms play an important role in hypertrophic scarring and point to an involvement of cell-mediated immune phenomena.

Full text

PDF
350

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bloch E. F., Hall M. G., Jr, Denson M. J., Slay-Solomon V. General immune reactivity in keloid patients. Plast Reconstr Surg. 1984 Mar;73(3):448–451. doi: 10.1097/00006534-198403000-00020. [DOI] [PubMed] [Google Scholar]
  2. Crepaldi T., Fasano M. E., Frattasio C., Centis D., Curtoni E. S., Richiardi P. Identification of anti-DQ alloantisera correlated with DR5. J Immunogenet. 1985 Dec;12(6):301–308. [PubMed] [Google Scholar]
  3. Czernielewski J. M., Bagot M. Class II MHC antigen expression by human keratinocytes results from lympho-epidermal interactions and gamma-interferon production. Clin Exp Immunol. 1986 Nov;66(2):295–302. [PMC free article] [PubMed] [Google Scholar]
  4. Czernielewski J. M. Mixed skin cell-lymphocyte culture reaction (MSLR) as a model for the study of lympho-epidermal interactions. Br J Dermatol. 1985 Jul;113 (Suppl 28):17–23. doi: 10.1111/j.1365-2133.1985.tb15622.x. [DOI] [PubMed] [Google Scholar]
  5. Janssen de Limpens A. M., Cormane R. H. Studies on the immunologic aspects of keloids and hypertrophic scars. Arch Dermatol Res. 1982;274(3-4):259–266. doi: 10.1007/BF00403728. [DOI] [PubMed] [Google Scholar]
  6. Ketchum L. D., Cohen I. K., Masters F. W. Hypertrophic scars and keloids. A collective review. Plast Reconstr Surg. 1974 Feb;53(2):140–154. doi: 10.1097/00006534-197402000-00004. [DOI] [PubMed] [Google Scholar]
  7. Kischer C. W., Shetlar M. R., Shetlar C. L., Chvapil M. Immunoglobulins in hypertrophic scars and keloids. Plast Reconstr Surg. 1983 Jun;71(6):821–825. doi: 10.1097/00006534-198306000-00015. [DOI] [PubMed] [Google Scholar]
  8. Lampert I. A. Expression of HLA-DR (Ia like) antigen on epidermal keratinocytes in human dermatoses. Clin Exp Immunol. 1984 Jul;57(1):93–100. [PMC free article] [PubMed] [Google Scholar]
  9. Lecchi M., Lovisone E., Genetta C., Peruccio D., Resegotti L., Richiardi P. Gamma-IFN induces a differential expression of HLA-DR, DQ and DP antigens on peripheral blood myeloid leukemic blasts at various stages of differentiation. Leuk Res. 1989;13(3):221–226. doi: 10.1016/0145-2126(89)90015-5. [DOI] [PubMed] [Google Scholar]
  10. Londei M., Lamb J. R., Bottazzo G. F., Feldmann M. Epithelial cells expressing aberrant MHC class II determinants can present antigen to cloned human T cells. Nature. 1984 Dec 13;312(5995):639–641. doi: 10.1038/312639a0. [DOI] [PubMed] [Google Scholar]
  11. Malavasi F., Milanese C., Fabbi M., Richiardi P., Caligaris-Cappio F., Ferrero E., Roggero S., Dellabona P., Ceppellini R. Generation and characterization of murine monoclonal antibodies against HLA Class II molecules. Diagn Immunol. 1984;2(1):53–62. [PubMed] [Google Scholar]
  12. McDonald W. S., Deitch E. A. Hypertrophic skin grafts in burned patients: a prospective analysis of variables. J Trauma. 1987 Feb;27(2):147–150. doi: 10.1097/00005373-198702000-00008. [DOI] [PubMed] [Google Scholar]
  13. Natali P. G., Segatto O., Ferrone S., Tosi R., Corte G. Differential tissue distribution and ontogeny of DC-1 and HLA-DR antigens. Immunogenetics. 1984;19(2):109–116. doi: 10.1007/BF00387853. [DOI] [PubMed] [Google Scholar]
  14. Natali P., Bigotti A., Cavalieri R., Nicotra M. R., Tecce R., Manfredi D., Chen Y. X., Nadler L. M., Ferrone S. Gene products of the HLA-D region in normal and malignant tissues of nonlymphoid origin. Hum Immunol. 1986 Feb;15(2):220–233. doi: 10.1016/0198-8859(86)90028-5. [DOI] [PubMed] [Google Scholar]
  15. Quismorio F. P., Bland S. L., Friou G. J. Autoimmunity in thermal injury: occurrence of rheumatoid factors, antinuclear antibodies and antiepithelial antibodies. Clin Exp Immunol. 1971 May;8(5):701–711. [PMC free article] [PubMed] [Google Scholar]
  16. Radka S. F., Charron D. J., Brodsky F. M. Class II molecules of the major histocompatibility complex considered as differentiation markers. Hum Immunol. 1986 Aug;16(4):390–400. doi: 10.1016/0198-8859(86)90065-0. [DOI] [PubMed] [Google Scholar]
  17. Shakespeare P. G., van Renterghem L. Some observations on the surface structure of collagen in hypertrophic scars. Burns Incl Therm Inj. 1985 Feb;11(3):175–180. doi: 10.1016/0305-4179(85)90065-8. [DOI] [PubMed] [Google Scholar]
  18. Volc-Platzer B., Majdic O., Knapp W., Wolff K., Hinterberger W., Lechner K., Stingl G. Evidence of HLA-DR antigen biosynthesis by human keratinocytes in disease. J Exp Med. 1984 Jun 1;159(6):1784–1789. doi: 10.1084/jem.159.6.1784. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Wick G., Hála K., Wolf H., Ziemiecki A., Sundick R. S., Stöffler-Meilicke M., DeBaets M. The role of genetically-determined primary alterations of the target organ in the development of spontaneous autoimmune thyroiditis in obese strain (OS) chickens. Immunol Rev. 1986 Dec;94:113–136. doi: 10.1111/j.1600-065x.1986.tb01167.x. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES